Immune dysregulation in Ethiopian immigrants in Israel: Relevance to helminth infections?

Clinical and Experimental Immunology

Volumn 103, Issue 2, 1996, Pages 239-243

  Bentwich, Z ^a,c   Weisman, Z ^a   Moroz, C ^b   Bar Yehuda, S ^a   Kalinkovich, A ^a  

^a HEBREW UNIVERSITY   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c KAPLAN HOSPITAL   (Israel)

Author keywords

Cytokines; Ethiopian immigrants; Helminth; Immune dysregulation; Infections; T helper cell subsets

Indexed keywords

CYTOKINE; GAMMA INTERFERON;

ARTICLE; CONTROLLED STUDY; ETHIOPIA; FEMALE; HELMINTHIASIS; HOST RESISTANCE; HUMAN; IMMIGRANT; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOREGULATION; ISRAEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030025111     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-612.x     Document Type: Article

References (32)

1. Hori H, Watanabe M, Sakurai M. Infectious diseases in African children. Acta Pediatr Jpn 1993; 35:553-8.
2. Piot P, Goeman J, Laga M. The epidemiology of HIV and AIDS in Africa. In: Essex M, Mboup S, Kanki PJ, Kalengayi MR, eds. AIDS in Africa. New York: Raven Press, Ltd, 1994: 157-72.
3. Anzala OA, Nagelkerke NJD, Bwayo JJ et al. Rapid progression to disease in African sex workers with human immunodeficiency virus type I infection. J Infect Dis 1995; 171:686-9.
4. The working group on mother-to-child transmission of HIV. Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies. J Acquir Immune Def Syndr Hum Retrovir 1995; 3:506-10.
5. N'Galy B, Ryder RW, Bila K et al. Human immunodeficiency virus infection among employes in an African hospital. N Engl J Med 1988; 319:1123-7.
6. Berkley S. AIDS in the developing world: an epidemiologic overview. Clin Infect Dis 1993; 17(Suppl.2):S329-36.
7. Gilks CF. The clinical challenge of the HIV epidemic in the developing world. Lancet 1993; 342:1037-9.
8. Bentwich Z, Kalinkovich A, Weizman Z. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 1995; 16:187-91.
9. Moroz C, Bessler H, Lurie Y, Shaklai M. New monoclonal antibody enzymoassay for the specific measurement of placental ferritin isotype in hematologic malignancies. Exp Hematol 1987; 15:258-62.
10. + cell numbers and clinical staging singing. J Clin Invest 1989; 84:1892-9.
11. Birx DL, Redfield RR, Tencer K, Fowler A, Burke DS, Tosato G. Induction of interleukin-6 during human immunodeficiency virus infection. Blood 1990; 76:2303-10.
12. Nordan RP, Potter M. A macrophage-derived factor required by plasmocytomas for survival and proliferation in vitro. Science 1986; 233:566-7.
13. Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 1989; 119:203-10.
14. Novick D, Engelmann H, Revel M, Leitner O, Rubinstein M. Monoclonal antibodies to the soluble human IL-6 receptor: Affinity purification, ELISA, and inhibition of ligand binding. Hybridoma 1991; 10:137-46.
15. Aderka D, Engelmann H, Hornik V, Skornick Y, Levo Y, Wallach D, Kushtai G. Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Cancer Res 1991; 51:5602-7.
16. Engelman H, Holtmann H, Brakebusch C et al. Antibodies to a soluble form of tumor necrosis factor (TNF) receptor have TNF-like activity. J Biol Chem 1990; 265:14497-504.
17. Engelman H, Novick D, Wallach D. Two tumor necrosis factor binding proteins purified from human urine. J Biol Chem 1990; 265:1531-6.
18. Kalinkovich A, Maayan S, Weisman Z, Harpaz N, Bentwich Z. Immune activation, a co-factor for HIV transmission in Thailand? Lancet 1994; 343:1506-7.
19. Nahmias J, Greenberg Z, Berger SA, Hornstein L, Bilgury B, Abel B, Kutner S. Health profile of Ethiopian immigrants in Israel: an overview. Isr J Med Sci 1993; 29:338-43.
20. Hodes RM, Kloos H. Health and medical care in Ethiopia. N Engl J Med 1988; 319:918-24.
21. Bundy DAP, Medley GF. Immuno-epidemiology of human geohelminthiasis: ecological and imunological determinants of worm burden. Parasitology 1992; 104:5105-19.
22. Maizels RM, Bundy DAP, Selkirk EM, Smith DFS, Anderson RM. Immunological modulation and evasion by helminth parasites in human populations. Nature 1993; 365:797-805.
23. Romagnani S. Lymphokine production by human T cells in disease states. Ann Rev Immunol 1994; 12:227-58.
24. Romagnani S. Biology of human Th1 and Th2 cells. J Clin Immunol 1995; 15:121-9.
25. Powrie F, Coffman RL. Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol Today 1993; 14:270-4.
26. Moroz C, Misrock SL, Siegal FP. Isoferritins in HIV infection: relation to clinical stage, CD8 lymphocyte binding and the pathogenesis of AIDS. AIDS 1989; 3:11-16.
27. + lymphocytes. Clin Diagn Lab Immunol 1995; 2:225-6.
28. Fauci AS. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 1993; 262:1011-8.
29. + cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance. Proc Natl Acad Sci USA 1993; 90:948-52.
30. Perlman E, Kazura JW, Hazlett FE, Boom WH. Modulation of murine cytokine responses to mycobacterial antigens by helminth-induced T helper 2 cell responses. J Immunol 1993; 151:4857-64.
31. Folks TM, Rowe T, Villinger F et al. Hyperimmune activation and progression to AIDS in rhesus macaques. Europ Cytokine Netw Special Issue, March, 1995; 77(Abstr.).
32. Bentwich Z, Wainberg MA. Host immunity and the course of HIV infection. Isr J Med Sci 1993; 29(Suppl.):34-36.